Griswold, D E <br/><br/>
SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Nov 1998 
 - 705-11 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-3565 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3',5'-Cyclic-AMP Phosphodiesterases--antagonists & inhibitors<br/>Adoptive Transfer<br/>Animals<br/>Cyclic Nucleotide Phosphodiesterases, Type 4<br/>Cyclohexanecarboxylic Acids--pharmacology<br/>Humans<br/>Interleukin-4--antagonists & inhibitors<br/>Male<br/>Mice<br/>Mice, Inbred Strains<br/>Monocytes<br/>Nitriles<br/>Phosphodiesterase Inhibitors--pharmacology<br/>Pyrrolidinones--pharmacology<br/>Rolipram<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors